Insider · CIK 0001458506

Hamdy Ahmed MD

Reports to the SEC for 3 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001458506

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-20	CRISCURIS INCC Conversion	CMO	CConversion	+66.7K sh	—	—	66,667
2026-03-20	CRISCURIS INC · Series B Convertible Preferred StockC Conversion	CMO	CConversion	−50 sh	—	—	0
2026-03-17	CRISCURIS INC · Series B Convertible Preferred StockA Award	CMO	AAward	+50 sh	—	—	50
2026-03-17	CRISCURIS INC · Series A Warrant (right to buy)A Award	CMO	AAward	+66.7K sh	—	—	66,667
2026-03-17	CRISCURIS INC · Series B Warrant (right to buy)A Award	CMO	AAward	+66.7K sh	—	—	66,667
2026-03-17	CRISCURIS INC · Series C Warrant (right to buy)A Award	CMO	AAward	+66.7K sh	—	—	66,667
2025-05-01	CRISCURIS INC · Employee stock option (right to buy)A Award	CMO	AAward	+200K sh	$2.48	+$496K	200,000
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−128K sh	—	—	0
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+128K sh	—	—	127,500
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−60K sh	—	—	0
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+60K sh	—	—	60,000
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−60K sh	—	—	0
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+60K sh	—	—	60,000
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−90K sh	—	—	0
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+90K sh	—	—	90,000
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−147K sh	—	—	0
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+147K sh	—	—	146,746
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−53.3K sh	—	—	0
2024-08-12	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+53.3K sh	—	—	200,000
2024-05-23	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+53.3K sh	—	—	200,000
2024-03-07	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+147K sh	—	—	146,746
2023-08-10	VINCVincerx Pharma, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,400 sh	$0.96	+$5,167.26	96,060
2023-08-09	VINCVincerx Pharma, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+16.9K sh	$0.95	+$16K	90,660
2023-02-15	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+90K sh	—	—	90,000
2022-12-14	VINCVincerx Pharma, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+35.3K sh	$0.87	+$30.5K	73,760
2022-11-15	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+60K sh	—	—	60,000
2022-08-25	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+60K sh	—	—	60,000
2022-06-23	VINCVincerx Pharma, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+24.2K sh	$1.41	+$34.1K	38,480
2022-02-14	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+128K sh	—	—	127,500
2021-12-22	VINCVincerx Pharma, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+6,450 sh	$10.02	+$64.6K	14,280
2021-06-29	VINCVincerx Pharma, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+7,830 sh	$12.77	+$100K	7,830
2020-12-23	VINCVincerx Pharma, Inc.A Award	Director, Chief Executive Officer	AAward	+1.62M sh	—	—	1,618,199
2011-04-29	PHARMACYCLICS INCJ Other	Chief Medical Officer	JOther	+5,011 sh	$1.61	+$8,050.172	11,966
2010-10-29	PHARMACYCLICS INCJ Other	Chief Medical Officer	JOther	+4,945 sh	$1.61	+$7,944.143	6,955
2010-10-13	PHARMACYCLICS INCEmployee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+30K sh	—	—	30,000
2010-10-05	PHARMACYCLICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+15K sh	$0.73	+$11K	17,010
2010-10-05	PHARMACYCLICS INCS Sale	Chief Medical Officer	SSale	−15K sh	$8.20	−$123K	2,010
2010-10-05	PHARMACYCLICS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−15K sh	—	—	285,000
2010-04-11	PHARMACYCLICS INCEmployee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+30K sh	$7.19	+$216K	30,000
2009-10-30	PHARMACYCLICS INCJ Other	Chief Medical Officer	JOther	+1,000 sh	$1.06	+$1,062.5	1,000
2009-03-10	PHARMACYCLICS INCOption (right to buy)A Award	Chief Medical Officer	AAward	+300K sh	—	—	300,000

Recent filings

Accepted (ET)
Mar 234
Hamdy Ahmed MD0001108205-26-000039
SEC(opens sec.gov)
Mar 184
Hamdy Ahmed MD0001108205-26-000027
SEC(opens sec.gov)
May 54
Hamdy Ahmed MD0001108205-25-000042
SEC(opens sec.gov)
Aug 144
Hamdy Ahmed MD0000950170-24-097328
SEC(opens sec.gov)
May 294
Hamdy Ahmed MD0000950170-24-066201
SEC(opens sec.gov)

Companies

Address

128 SPRING STREET BUILDING C - SUITE 500

LEXINGTON, MA, 02421